Global Prevalence Of Diabetes - WHO

2y ago
26 Views
2 Downloads
225.67 KB
7 Pages
Last View : 1d ago
Last Download : 2m ago
Upload by : Grady Mosby
Transcription

Epidemiology/Health Services/Psychosocial ResearchO R I G I N A LA R T I C L EGlobal Prevalence of DiabetesEstimates for the year 2000 and projections for 2030SARAH WILD, MB BCHIR, PHD1GOJKA ROGLIC, MD2ANDERS GREEN, MD, PHD, DR MED SCI3RICHARD SICREE, MBBS, MPH4HILARY KING, MD, DSC2OBJECTIVE — The goal of this study was to estimate the prevalence of diabetes and thenumber of people of all ages with diabetes for years 2000 and 2030.RESEARCH DESIGN AND METHODS — Data on diabetes prevalence by age and sexfrom a limited number of countries were extrapolated to all 191 World Health Organizationmember states and applied to United Nations’ population estimates for 2000 and 2030. Urbanand rural populations were considered separately for developing countries.RESULTS — The prevalence of diabetes for all age-groups worldwide was estimated to be2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to risefrom 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in menthan women, but there are more women with diabetes than men. The urban population indeveloping countries is projected to double between 2000 and 2030. The most importantdemographic change to diabetes prevalence across the world appears to be the increase in theproportion of people 65 years of age.CONCLUSIONS — These findings indicate that the “diabetes epidemic” will continue evenif levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely thatthese figures provide an underestimate of future diabetes prevalence.Diabetes Care 27:1047–1053, 2004The number of people with diabetesis increasing due to populationgrowth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. Quantifying the prevalenceof diabetes and the number of people affected by diabetes, now and in the future,is important to allow rational planningand allocation of resources.Estimates of current and future diabetes prevalence have been publishedpreviously (1–3). Since these reports ap-peared, further epidemiological data havebecome available for several countries inAfrica and the Middle East and for India.The sources of these data are identified inTable 1.This report provides estimates of theglobal prevalence of diabetes in the year2000 (as used in the World Health Organization [WHO] Global Burden of Disease Study) and projections for 2030. Itprovides a sequel to the report describingestimates of the global burden of diabetes From the 1Public Health Sciences, University of Edinburgh, Edinburgh, Scotland; the 2Department ofNon-Communicable Diseases, World Health Organization, Geneva, Switzerland; the 3Department of Epidemiology and Social Medicine, University of Aarhus, Aarhus, Denmark; and the 4International DiabetesInstitute, Caulfield, Victoria, Australia.Address correspondence and reprint requests to Dr. Sarah Wild, Public Health Sciences, University ofEdinburgh, Teviot Place, Edinburgh, EH8 9AG, Scotland. E-mail: sarah.wild@ed.ac.uk.Received for publication 18 October 2003 and accepted in revised form 26 January 2004.S.W. received honoraria for speaking engagements from Bayer Corporation. A.G. is a paid consultant ofNovo Nordisk.Additional information for this article can be found in an online appendix at http://care.diabetesjournals.org.Abbreviations: IDF, International Diabetes Federation; WHO, World Health Organization.A table elsewhere in this issue shows conventional and Système International (SI) units and conversionfactors for many substances. 2004 by the American Diabetes Association.DIABETES CARE, VOLUME 27, NUMBER 5, MAY 2004in 1990 (2) using newer data and differentmethods for estimating age-specific prevalence. As before, the estimates are basedon demographic changes alone with theconservative assumption that other riskfactor levels such as obesity and physicalactivity remain constant (in developedcountries) or are accounted for by urbanization (in less developed countries). Thecurrent estimates include all age-groups,and age-specific data are presented (online appendix [available at http://care.diabetesjournals.org]) to allow comparison with previous estimates that were foradults only (2). As most data sources donot distinguish between type 1 and type 2diabetes in adults, it is not possible topresent data separately for subtypes ofdiabetes.RESEARCH DESIGN ANDMETHODS — Diabetes prevalencedata for adults (ⱖ20 years of age) werederived from studies meeting the following criteria: a defined, population-basedsample and diagnosis of diabetes based onoptimal WHO criteria (a venous plasmaglucose concentration of 11.1 mmol/l2 h after a 75-g glucose tolerance test).The exceptions to the latter criterion werethe study in China, for which a test mealwas used (4), and the study in Tanzania(5), in which fasting glucose alone gave ahigher prevalence of diabetes than a previous study that used the optimal WHOcriteria.Prevalence estimates for type 1 diabetes for people 20 years of age for individual countries were estimated fromavailable incidence data using methodsdescribed in the International DiabetesFederation (IDF) Diabetes Atlas 2000 (6).Population-based data are not availablefor type 2 diabetes in people 20 years ofage, and this group has been excludedfrom these estimates.Age- and sex-specific estimates for diabetes prevalence were extrapolated toother countries using a combination ofcriteria including geographical proximity,ethnic, and socioeconomic similaritiesapplied by the authors with the adviceof the WHO regional officer and other1047

Global prevalence of diabetesTable 1 —List of diabetes prevalence studies by country of study giving sample size, age-group, and the countries to which the data wereextrapolatedCountry of study, year, andreference*Australia, 2000 (21)†Bolivia, 1998 (22)†Brazil, 1988/1989 (23)†Cameroon, published 1997 (24)†China, 1994 (4)†‡Colombia, 1988/1989 (25)Sample 030–6924–74224,25167025–64ⱖ30Fiji, 1980 (26)‡1,709ⱖ20Ghana, 1998 ⱖ30ⱖ1525–74ⱖ35ⱖ2050–742,9635709671,606 urban white 69India, 2000 (28)†Iran, 1999/2000 (29)†Israel (30)†‡Japan Funagata, 1990–1992 (31)†Jordan (32)†Lebanon†§Malta (33)†Mauritius (34)†‡Mongolia (35)†‡Nauru (36)†‡Netherlands, 1989–1992 (37)†Oman, 1991 (38)Pakistan: rural Baluchistan (39)†Pakistan: Sindh, 1994 (40)Paraguay, 1991/1992 (41)†Poland¶Russia㛳Samoa (42)†‡Saudi Arabia (43)†‡Singapore (44)†‡South Africa (45)†South Korea/Republic of Korea (46)†Spain (47)†Sudan (48)†Tanzania, 1996/1997 (5)†Trinidad, 1977–1981 (49)Tunisia, 1976/1977, 1980/1981 (50)Turkey (51)†3,826 urban1,787 rural24,788ⱖ20ⱖ20United Arab Emirates, 2000†‡#U.S., 1988–1994 (52)†Uzbekistan, 1996 *1,121ⱖ25Additional countries that estimates were applied toNew ZealandEcuador, PeruArgentina, Chile, Cuba, Mexico, Uruguay, VenezuelaAngola, Central African Republic, Congo, Gabon, Guinea, SaoTome, and PrincipeNorth Korea/Democratic People’s Republic of Korea‡Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua,PanamaKiribati‡, Marshall Islands‡, Micronesia (Federated States)‡,Palau‡, Papua New Guinea‡, Solomon Islands‡, Vanuatu‡Benin, Burkina Faso, Cape Verde, Chad, Cote d’Ivoire,Equatorial Guinea, Guinea Bissau, Gambia, Liberia,Nigeria, Senegal, Sierra Leone, TogoBangladesh, Bhutan, Sri Lanka, Maldives, NepalAzerbaijan, Iraq, YemenSyria, urban EgyptSeychellesAustria, Belgium, Denmark, Finland, France, Germany,Iceland, Ireland, Luxembourg, Norway, Sweden,Switzerland, U.K.QatarAfghanistanSurinameBosnia, Croatia, Czech Republic, Estonia, Hungary, Latvia,Lithuania, Serbia, Slovakia, Slovenia, the Former YugoslavRepublic of Macedonia, UkraineCook Islands‡, Niue‡, Tonga‡, Tuvalu‡Bahrain‡, Kuwait‡Brunei‡, Indonesia, Malaysia, Philippines, ThailandBotswana, Lesotho, Namibia, Swaziland, ZimbabweAndorra, Italy, Monaco, San Marino, PortugalEritrea, Ethiopia, Mali, Mauritania, NigerBurundi, Comoros, Democratic Republic of the Congo,Djibouti, Kenya, Madagascar, Malawi, Mozambique,Rwanda, Somalia, Uganda, ZambiaAntigua and Barbuda‡, Bahamas‡, Barbados, Belize,Dominica, Dominican Republic, Grenada‡, Guyana, Haiti,Jamaica, St. Kitts and Nevis‡, St. Lucia‡, St. Vincent andthe Grenadines‡Algeria, Libya, MoroccoAlbania, Belarus, Bulgaria, Cyprus, Greece, Moldova,RomaniaCanadaArmenia‡, Georgia‡, Kazakhstan‡, Kyrgyzstan‡, Tajikistan‡,Turkmenistan‡Cambodia, Laos, Myanmar*Year indicates year of study, if given, or year of publication. †Indicates data that were not used in estimates for 1990. ‡Indicates same diabetes prevalence data usedfor urban and rural populations. §I. Salti, M. Khogali, S. Alam, N. Nassar, A. Masri, personal communication. 㛳E. Shubnikov, personal communication. ¶Z. Szybinski,W. Zukowski, R. Rita, J. Sieradzki, I. Turska-Karbowska, M. Gizler, personal communication. #M. Malik, A. Bakir, B. Abi Saab, G.R., H.K., personal communication.**P. Khi, personal communication.1048DIABETES CARE, VOLUME 27, NUMBER 5, MAY 2004

Wild and AssociatesTable 2 —Estimated numbers of people with diabetes by region for 2000 and 2030 and summary of population changesRegion (all ages)Established market economiesFormer socialist economiesIndiaChinaOther Asia and IslandsSub-Saharan AfricaLatin America and the CaribbeanMiddle Eastern CrescentWorld200020302000–2030Number ofpeople withdiabetesNumber ofpeople withdiabetesPercentage ofchange in numberof people withdiabetes*Percentage ofchange in totalpopulation*Percentage ofchange inpopulation 65years of age*Percentage ofchange in 9 11591192569461*A positive value indicates an increase, a negative value indicates a decrease.experts. Table 1 shows the studies usedand the countries to which data wereextrapolated.Surveys were generally performed onmiddle-aged populations, and data aremore limited at younger and older ages.Data on diabetes prevalence are usuallypresented in broad age bands, which suggest a biologically implausible step-likeincrease in diabetes prevalence with increasing age. DISMOD II software (available from http://www3.who.int/whosis)was used to produce smoothed, agespecific estimates of diabetes prevalencefrom the available data from each study.Further details on DISMOD II have beenpublished elsewhere (7). In summary,age- and sex-specific diabetes prevalence(derived from the studies listed in Table1), remission (assumed to be zero), andestimates of relative risk of mortalityamong people with diabetes (see below)were entered into models. The model output provides estimates of prevalence, incidence, and mortality that are consistentwith one another (7).Estimates of relative risk of all-causemortality among people with diabetes, byage and sex, were derived from the limited number of cohort studies that provide this information (8 –10). Estimatedrelative risks for all-cause mortalityranged between 1 (for the oldest agegroup, ⱖ80 years of age) and 4.1 (for20 –39 years of age) for men and between1 (for ⱖ80 years of age) and 6.7 (for20 –39 years of age) for women. Furtherinformation on the estimation of agespecific relative risks is available in thedraft Global Burden of Disease 2000 docDIABETES CARE, VOLUME 27, NUMBER 5, MAY 2004umentation (11). Mortality data were derived from developed countries (U.K.,Sweden, and U.S.). As no information wasavailable for developing countries, thesame relative risks were assumed to apply. Data are required to test the validityof this assumption. Survival is unlikely tobe better in developing countries than developed countries, and any bias in the approach we have taken would lead toconservative estimates of incidence of diabetes in developing countries but wouldnot affect estimates of prevalence. Estimates of incidence and mortality arenot presented in this report but areavailable from the authors and from thedraft Global Burden of Disease 2000documentation (11).The prevalence estimates were applied to population estimates for individ-ual countries for 2000 and 2030, whichwere produced by the United NationsPopulation Division (12). Conventional,albeit simplistic, definitions of developedcountries (Europe including former socialist economies, North America, Japan,Australia, and New Zealand) and less developed countries (all other countries)were used. In keeping with previous estimates, prevalence of diabetes was assumed to be similar in urban and ruralareas of developed countries (2). For developing countries, urbanization wasused as a proxy measure of the increasedrisk of diabetes associated with altereddiet, obesity, decreased physical activity,and other factors such as stress, which areassumed to differ between urban and rural populations. For most developingcountries, the prevalence of diabetes inFigure 1—Global diabetes prevalence by age and sex for 2000.1049

Global prevalence of diabetesDevelopment Report 1993 (14) and theGlobal Burden of Disease 1990 study wasretained. Data on population size and estimated numbers of people with diabetesfor individual countries were combinedto give regional estimates of diabetesprevalence.Figure 2—Estimated number of adults with diabetes by age-group, year, and countries for thedeveloped and developing categories and for the world.rural areas was assumed to be one-halfthat of urban areas, based on the ratio observed in a number of population studiesand as used in previous estimates (1). Forsome populations in developing countries (small islands and populations forwhich prevalence data were derived fromstudies combining urban and rural populations), a single estimate of diabetes prev1050alence was used. In the current estimates,on the advice of local experts, the prevalence of diabetes in rural areas was assumed to be one-quarter that of urbanareas for Bangladesh, Bhutan, India, theMaldives, Nepal, and Sri Lanka (13).To facilitate comparisons with previous estimates, the regional grouping ofcountries originally used in the WorldRESULTS — Detailed information onthe estimated number of people with diabetes, population size, and prevalencefor individual countries is given in the online appendix. The regional summariesare shown in Table 2.Assuming that age-specific prevalence remains constant, the number ofpeople with diabetes in the world is expected to approximately double between2000 and 2030, based solely upon demographic changes. The greatest relative increases will occur in the Middle EasternCrescent, sub-Saharan Africa, and India.The greatest absolute increase in the number of people with diabetes will be in India. Most of the expected populationgrowth between 2000 and 2030 will beconcentrated in the urban areas of theworld (15). The most striking demographic change in global terms will be theincrease in the proportion of the population 65 years of age (see Table 2).The importance of age on the prevalence of diabetes is illustrated in Fig. 1,which shows sex-specific estimates of diabetes prevalence by age. Globally, diabetes prevalence is similar in men andwomen but it is slightly higher in men 60 years of age and in women at olderages. Overall, diabetes prevalence ishigher in men, but there are more womenwith diabetes than men (data availablefrom the authors). The combined effectof a greater number of elderly womenthan men in most populations and theincreasing prevalence of diabetes withage is the most likely explanation for thisobservation.In developing countries, the majorityof people with diabetes are in the 45- to64-year age range, similar to the findingreported previously (2). In contrast, themajority of people with diabetes in developed countries are 64 years of age. By2030, it is estimated that the number ofpeople with diabetes 64 years of agewill be 82 million in developing countries and 48 million in developed countries. The age distribution of the numberof people with diabetes in developedDIABETES CARE, VOLUME 27, NUMBER 5, MAY 2004

Wild and AssociatesTable 3 —List of countries with the highest numbers of estimated cases of diabetes for 2000and 203020002030RankingCountryPeople withdiabetes (millions)CountryPeople withdiabetes akistanRussian .911.311.18.97.86.7and developing countries is illustrated inFig. 2.The 10 countries estimated to havethe highest numbers of people with diabetes in 2000 and 2030 are listed in Table3. The “top three” countries are the sameas those identified for 1995 (2) (India,China, and U.S.). Bangladesh, Brazil, Indonesia, Japan, and Pakistan also appearin the lists for both 2000 and 2030. TheRussian Federation and Italy appear in thelist for 2000 but are replaced by the Philippines and Egypt for 2030, reflecting anticipated changes in the population sizeand structure in these countries betweenthe two time periods.CONCLUSIONS — The number ofcases of diabetes worldwide in 2000among adults ⱖ20 years of age is estimated to be 171 million. This figure is11% higher than the previous estimate of154 million (2). Estimates of total population size and proportion of people 64years of age in 2000 used in the previousreport were higher than those used in thisreport, and therefore demographicchanges cannot account for the discrepancy. The higher prevalence is more likelyto be explained by a combination of theinclusion of surveys reporting higherprevalence of diabetes than was assumedpreviously and different data sources forsome countries. The IDF Diabetes Atlas2000 used different and less stringent criteria for the inclusion of studies to estimate prevalence of diabetes for 20- to 79year-old individuals in the 172 IDFmember countries ( 90% of the population of the world) (6). It was estimatedthat there were 151 million people withDIABETES CARE, VOLUME 27, NUMBER 5, MAY 2004diabetes in this subpopulation in 2000.Despite methodological differences, thiswas similar to the present estimate for acomparable population of 147 million.The IDF has subsequently released estimates of the numbers of people with diabetes for 2003 and forecasts for 2025 of194 million and 334 million, respectively (16).Even if the prevalence of obesity remains stable until 2030, which seems unlikely, it is anticipated that the number ofpeople with diabetes will more than double as a consequence of population agingand urbanization. In the light of the observed increase in prevalence of obesity inmany countries of the world and the importance of obesity as a risk factor for diabetes, the number of cases of diabetes in2030 may be considerably higher thanstated here. Increasing evidence of effective interventions, including changes indiet and physical activity or pharmacological treatment to reduce prevalence of diabetes, provides an impetus for widerintroduction of preventive approaches(17–19). Furthermore, improved survivalmay contribute to increasing prevalenceof diabetes in the future especially in developed countries (20).As with previous similar studies,these estimates are limited by a paucity ofdata, particularly for Eastern Europe andSoutheast Asia, and by the assumptionsrequired to generate the estimates. It ispossible that individual studies are notrepresentative of the whole country inwhich they were performed, and it islikely that extrapolation of results toneighboring countries may give inaccurate estimates of diabetes prevalence. Anew approach to estimatin

Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030 SARAH WILD, MB BCHIR, PHD 1 GOJKA ROGLIC,MD 2 ANDERS GREEN, MD, PHD, DR MED SCI 3 RICHARD SICREE, MBBS, MPH 4 HILARY KING MD DSC 2 OBJECTIVE— The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030.

Related Documents:

Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia American Diabetes Association. Facts and Figures. Available at: http://www.diabetes.org/ada/facts.asp. Accessed January 18, 2000. Diagnosed Type 1 Diabetes 0.5 - 1.0 Million Diagnosed Type 2 Diabetes 10.3 Million Undiagnosed Diabetes 5.4 Million Prevalence of Diabetes in the US 3

PREVALENCE OF GESTATIONAL DIABETES A study on prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010 shows that the prevalence of gestational diabetes is 9.2% in 2010,8.5% in 2009-2010 and 8.1% in 2007-2008. (DeSisto, Kim & Sharma, 2014).

Prevalence¶ of Self-Reported Obesity Among U.S. Adults by State and Territory, BRFSS, 2016 Summary q No state had a prevalence of obesity less than 20%. q 3 states and the District of Columbia had a prevalence of obesity between 20% and 25%. q 22 states and Guam had a prevalence of obesity between 25% and 30%. q 20 states, Puerto Rico, and Virgin Islands had a prevalence

Diabetes in the United States More than 29 million people in the U.S. have diabetes 8.1 million people with diabetes are undiagnosed 9.3% of the U.S. population 1.7 million Americans aged 20 years or older were newly diagnosed with diabetes in 2010 Every 19 seconds, someone is diagnosed with diabetes

Clinical Diabetes. 2017 Jan; 35(1)51-54. Speight J, Conn J, Dunning T, Skinner TC, Diabetes Australia. Diabetes Australia position statement. A new language for diabetes: improving communications with and about people with diabetes. Diabetes Res Clin Pract 2012 Sep; 97(3): 425- 31.

Type 2 Diabetes Type 2 diabetes, which used to be called adult-onset diabetes, can affect people at any age, even children. However, type 2 diabetes develops most often in middle-aged and older people. People who are overweight and inactive are also more likely to develop type 2 diabetes. Type 2 diabetes usually begins with insulin resistance—a

TABLE 57-3. Proposed Classification System for Diabetes in Pregnancy Gestational diabetes: diabetes diagnosed during pregnancy that is not clearly overt (type 1 or type 2) diabetes Type 1 Diabetes: Diabetes resulting from β-cell destruction, usually leading to absolute insulin deficiency a. Without vascular complications b.

-Animal Nutrition Report Categories: CSSF Activity Report Approved By: James Johnson, Agricultural Affairs Officer Prepared By: Swe Mon Aung, Agricultural Specialist Report Highlights: In July 2019, FAS sent five Myanmar private feed millers and importers to the United States on a Cochran Fellowship Program to learn more about feed and feed ingredients available in the United States poultry .